Project Scope This project is exploring the evolving global landscape of clinical trial transparency and will showcase the existing and emerging global requirements and best practices relating to clinical study submission requirements. The team have produced a poster on the global view of clinical trial transparency and disclosure events for a single study and product submissions which they presented at CSS 2018. This lead the team to develop a white paper investigating the evolving global landscape of clinical trial transparency and disclosure, focusing on submission related requirements. |
Project Leads | |
|---|---|
Anne Cutting |
Key Milestones
| Objective | Timeline |
|---|---|
| ||||||
|---|---|---|---|---|---|---|
| Evolving to reformat deliverable |
| Resources | |
|---|---|
| Poster Presented at CSS 2018 | Global View of Clinical Trial Transparency and Disclosure Events for a Single Study and Product Submissions |
Project Members | Organisation |
|---|---|
| Anne Cutting | GSK |
Christa Polidori | Regeneron |
George Allen | Janssen PharmaceuticalsResearch & Development |
Helle Gawrylewski | Hawkwood Consulting LLCConsulting |
Julie Holtzople | AstraZeneca |
Lora Killian | Pfizer |
Mark Gummel | Jazz Pharma |
| Nate Root | Ionis Pharmaceuticals |
| Praveen Kumar | Geninvo |
| Raina Agarwal | kinapseKinapse |
| Rene Allard | Industry |
| Renee Entzminger | Industry |
| Sherry Meeh | JJanssen Research & JDevelopment |
| Stephen Bamford | Janssen PharmaceuticalsResearch & Development |
| Teresa Armstrong | Eli Lilly |
| Tom Bosch | JJanssen Research & JDevelopment |
| Wendy Wimmer | Merck |